Cite
HARVARD Citation
Cruickshank, G. et al. (n.d.). Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery. Neuro-oncology. p. i1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cruickshank, G. et al. (n.d.). Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery. Neuro-oncology. p. i1. [Online].